Cite

HARVARD Citation

    Uribe‐Lewis, S. et al. (2022). Long‐term survival after low‐dose‐rate brachytherapy for prostate cancer: the Royal Surrey experience. BJU international. pp. 723-730. [Online]. 
  
Back to record